Contract With Customer, Liability, Gross

No definition available.

Name:	autl_ContractWithCustomerLiabilityGross
Namespace Prefix:	autl_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Number Of Development Payments

+ References

No definition available.

+ Details

Name:	autl_NumberOfDevelopmentPayments
Namespace Prefix:	autl_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number Of Freestanding Financial Instruments

+ References

No definition available.

+ Details

Name:	autl_NumberOfFreestandingFinancialInstruments
Namespace Prefix:	autl_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Revenue, Remaining Performance Obligation, Variable Consideration Amount

+ References

No definition available.

+ Details

Name:	autl_RevenueRemainingPerformanceObligationVariableConsiderationAmount
Namespace Prefix:	autl_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Revenue, Remaining Performance Obligation, Variable Consideration Amount, Agreement Inception

+ References

No definition available.

+ Details

Name:	autl_RevenueRemainingPerformanceObligationVariableConsiderationAmountAgreementInception
Namespace Prefix:	autl_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Royalty And Milestone Liability, Gross

+ References

No definition available.

+ Details

Name:	autl_RoyaltyAndMilestoneLiabilityGross
Namespace Prefix:	autl_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Collaborative Agreement, Liability, Additions

+ References

No definition available.

+ Details

Name:	autl_RoyaltyAndMilestoneLiabilityInitialRecognition
Namespace Prefix:	autl_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Units Of Accounting

+ References

No definition available.

+ Details

Name:	autl_UnitsOfAccounting
Namespace Prefix:	autl_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ClassOfWarrantOrRightLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-11

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479837/606-10-45-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-8

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479837/606-10-45-2

+ Details

Name:	us-gaap_ContractWithCustomerLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 55
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482949/835-30-55-8

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(a)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482900/835-30-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-6

+ Details

Name:	us-gaap_DebtInstrumentInterestRateEffectivePercentage
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_DebtInstrumentAxis=autl_BioNTechLiabilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=autl_BioNTechLicenseAndOptionsAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=autl_BlackstoneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=autl_BioNTechMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=autl_ObeCelProductMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Liabilities Related to Future Royalties and Milestones, Net - Narrative (Details) $ in Thousands			1 Months Ended			12 Months Ended
	Feb. 06, 2024 USD ($)	Nov. 06, 2021 USD ($)	Feb. 29, 2024 USD ($)	Dec. 31, 2022 USD ($) payment	Nov. 30, 2021 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2025 unit financialInstrument
Class of Warrant or Right [Line Items]
Number of development payments \| payment				2
Number of units of accounting \| unit							4
Number of freestanding financial instruments \| financialInstrument							1
Initial recognition of BioNTech liability						$ 38,335
BioNTech Liability
Class of Warrant or Right [Line Items]
Effective percentage						28.70%	28.70%
BioNTech License and Option Agreement
Class of Warrant or Right [Line Items]
Number of freestanding financial instruments \| financialInstrument							1
Blackstone
Class of Warrant or Right [Line Items]
Variable consideration amount, agreement inception		$ 150,000
Liability related to the sale of future royalties and sales milestones, net (Blackstone Financing Agreement), gross proceeds					$ 50,000
Remaining performance obligation, variable consideration amount		$ 100,000				$ 30,000
Liabilities related to future royalties and milestones, net - non-current				$ 35,000
BioNTech \| Obe-cel Product
Class of Warrant or Right [Line Items]
Remaining performance obligation, variable consideration amount	$ 100,000
Upfront payment paid	$ 40,000
Initial recognition of BioNTech liability			$ 38,300